Reported Jun 11, 2019 · Announced

Teva Pharmaceuticals USA, Inc. recalls GSMS Inc. Losartan potassium tablets due to Detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)

Teva Pharmaceuticals USA, Inc.

Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.

What you should do

Stop using the product and follow the return or refund instructions in the firm's announcement.

Is this the product you have?

  • Losartan potassium tablets BrandGSMS Inc.. Drugs

Why it was recalled

Detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)

The agency has not ranked the risk yet — treat the notice as a caution.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Teva Pharmaceuticals USA, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration

Read the FDA (recalls & safety alerts) notice

Data as of Sep 19, 5:08 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.